-
11061por Alcazer, Vincent, Miailhes, Patrick, Ramière, Christophe, Charre, Caroline, Cotte, Laurent“…BACKGROUND: Hepatitis C virus (HCV) infection is a recognised cause of secondary immune thrombocytopenia (ITP). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11062“…Since the advent of new direct acting antivirals (DAA), substantial changes in hepatitis C (HCV) treatment guidelines have occurred. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11063Trends and Gaps in National Blood Transfusion Services — 14 Sub-Saharan African Countries, 2014–2016por Kanagasabai, Udhayashankar, Chevalier, Michelle S., Drammeh, Bakary, Mili, Fatima D., Qualls, Michael L., Bock, Naomi, Benech, Irene, Nelson, Lisa J., Alemnji, George, Watts, D. Heather, Kimani, Daniel, Selenic, Dejana“…Ensuring availability of safe blood products through recruitment of voluntary, nonremunerated, blood donors (VNRDs) and prevention of transfusion-transmissible infections (TTIs), including human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), and syphilis, is important for public health (1,2). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11064“…Interestingly, F3 fibrosis in non-alcoholic fatty liver disease, hepatitis B virus and hepatitis C virus infections are associated with high risk of developing HCC. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11065por Müller-Durovic, Bojana, Grählert, Jasmin, Devine, Oliver P., Akbar, Arne N., Hess, Christoph“…Natural killer cells lacking expression of CD56 (CD56(neg) NK cells) have been described in chronic HIV and hepatitis C virus infection. Features and functions of CD56(neg) NK cells in the context of latent infection with CMV and / or EBV with age are not known. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11066“…The mechanism by which hepatitis C virus (HCV) causes fibrosis and other chronic liver diseases remains poorly understood. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11067“…MATERIAL/METHODS: There were 56 patients with primary liver cancer who were admitted to the hospital from July 2015 to October 2017 included in the liver cancer group, and 24 non-hepatoma patients (hepatitis A/hepatitis B/hepatitis C, liver cirrhosis, liver fibrosis, and fatty liver, alcoholic liver identified as a control group. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11068por Rewri, Parveen, Sharma, Madhavi, Lohan, Aprajita, Singh, Deepika, Yadav, Vibha, Singhal, Aparna“…PURPOSE: The aim of this study is to know practice pattern of cataract surgeons when operating on patients, positive for blood-borne viral infections (BBVIs), namely, hepatitis B virus, hepatitis C virus, and human immunodeficiency virus. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11069por Bagaglio, Sabrina, Messina, Emanuela, Hasson, Hamid, Galli, Andrea, Uberti-Foppa, Caterina, Morsica, Giulia“…Background: Little is known about the frequency or geographic distributions of naturally occurring resistance-associated substitutions (RASs) in the nonstructural protein 5A (NS5A) domain of hepatitis-C virus (HCV) genotype-3 (GT-3) different subtypes. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11070por Tarao, Kazuo, Nozaki, Akito, Ikeda, Takaaki, Sato, Akira, Komatsu, Hirokazu, Komatsu, Tatsuji, Taguri, Masataka, Tanaka, Katsuaki“…(a) hepatitis B virus liver disease: 0.37%→3.23% (8.73‐fold), (b) hepatitis C virus liver diseases: 0.68%→4.81% (7.07‐fold), (c) primary biliary cholangitis (0.26%→1.79%, 6.88‐fold), (d) autoimmune hepatitis (0.19%→0.53%, 2.79‐fold), and (e) NASH (0.03%→1.35%, 45.00‐fold). …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11071por Derakhshan, Mohammad H., Goodson, Nicola J., Packham, Jonathan, Sengupta, Raj, Molto, Anna, Marzo-Ortega, Helena, Siebert, Stefan“…We evaluated the association between SpA duration and upper gastrointestinal ulcers, hepatitis B (HBV), hepatitis C (HCV) and diverticulitis using data from a large international cross-sectional study. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11072por Chong, Pek Y., Shotwell, J. Brad, Miller, John, Price, Daniel J., Maynard, Andy, Voitenleitner, Christian, Mathis, Amanda, Williams, Shawn, Pouliot, Jeffrey J., Creech, Katrina, Wang, Feng, Fang, Jing, Zhang, Huichang, Tai, Vincent W.-F., Turner, Elizabeth, Kahler, Kirsten M., Crosby, Renae, Peat, Andrew J.“…[Image: see text] We previously described the discovery of GSK5852 (1), a non-nucleoside polymerase (NS5B) inhibitor of hepatitis C virus (HCV), in which an N-benzyl boronic acid was essential for potent antiviral activity. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11073“…METHODS: 50 type 2 Egyptian diabetic patients controlled on oral hypoglycemic drugs together with 20 age- and sex-matched healthy participants were enrolled in the study; all were subjected to complete history taking, BMI, fasting plasma glucose, HOMA-IR, ALT, AST, GGT, urea and creatinine, total lipid profile, hepatitis markers including hepatitis B surface antigen and hepatitis C virus antibodies, conjugated linoleic fatty acid “CLA,” and abdominal ultrasound for grading of NAFLD. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11074“…Ombitasvir, ritonavir and paritaprevir are three recently discovered directly acting antiviral drugs (DAADs) used in combined single dose tablet dosage form for treatment of hepatitis-C viral infections (HCV). The methods of analysis followed by quality control and research laboratories are required to be economic and fast; however, these methods can also produce huge amounts of chemical waste. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11075por Fejleh, M. Phillip, Thaker, Adarsh M., Kim, Stephen, Muthusamy, V. Raman, Sedarat, Alireza“…RESULTS: Patient 1 had hepatitis C cirrhosis and underwent liver transplantation with T tube placement at the site of biliary anastomosis. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11076“…Furthermore, it has been reported that alcohol accelerates hepatitis C virus-induced liver tumorigenesis through TLR4 signaling. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11077por Valean, Simona, Acalovschi, Monica, Dumitrascu, Dan L., Ciobanu, Lidia, Nagy, Georgiana, Chira, Romeo“…We aimed to provide a systematic literature review on the frequency of HCC in patients with AIH, after the discovery of hepatitis C virus (HCV), in order to avoid any possible confounding etiology. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11078por Koopsen, J., van Steenbergen, J. E., Richardus, J. H., Prins, M., Op de Coul, E. L. M., Croes, E. A., Heil, J., Zuure, F. R., Veldhuijzen, I. K.“…Chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are usually asymptomatic for decades, thus targeted screening can prevent liver disease by timely diagnosis and linkage to care. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11079“…Worldwide, 71 million individuals are chronically infected with Hepatitis C Virus (HCV). Chronic HCV infection can lead to potentially fatal outcomes including liver cirrhosis and hepatocellular carcinoma. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11080por Das, Undurti N.“…It has been suggested that hepatitis B virus (HBV)- and hepatitis C virus (HCV)-induced hepatic damage and cirrhosis and associated hypoalbuminemia, non-alcoholic fatty liver disease (NAFLD), and alcoholic fatty liver disease (AFLD) are due to an imbalance between pro-inflammatory and anti-inflammatory bioactive lipids. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto